Establishment Labs- Motiva USA LLC

Establishment Labs Holdings Inc. (NASDAQ: ESTA) is a global medical technology company specializing in breast health, aesthetics, and reconstruction solutions. Founded in 2004 in Costa Rica and publicly traded since 2018, the company manufactures silicone gel-filled breast implants under the Motiva brand, featuring proprietary technologies including Q Inside Safety Technology™ and SmoothSilk® surface treatments. The product portfolio includes Motiva SmoothSilk Round and Ergonomix implants for augmentation (FDA-approved with <1% device-complication rates), Motiva Flora® tissue expanders for breast reconstruction with integrated MRI-conditional ports, and Mia Femtech™ for minimally invasive breast harmony procedures. Products are distributed globally across 80+ countries to physicians, hospitals, and clinics, with Brazil as the largest market. The company maintains a strong R&D focus, supported by over 200 patent applications across 25 patent families and 50+ peer-reviewed scientific publications. Establishment Labs emphasizes evidence-based innovation, patient safety, and women's health empowerment.